TAMALIN
Basic information
Region (hg38): 12:52006946-52015889
Previous symbols: [ "GRASP" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TAMALIN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 30 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 30 | 2 | 1 |
Variants in TAMALIN
This is a list of pathogenic ClinVar variants found in the TAMALIN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-52007026-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
12-52007179-G-A | not specified | Uncertain significance (Jan 31, 2024) | ||
12-52007195-T-C | not specified | Uncertain significance (Jun 18, 2021) | ||
12-52007225-G-A | not specified | Uncertain significance (May 30, 2023) | ||
12-52009202-C-T | not specified | Uncertain significance (Nov 15, 2023) | ||
12-52009214-C-T | Benign (Jul 31, 2018) | |||
12-52011114-C-T | not specified | Uncertain significance (Jul 21, 2022) | ||
12-52011136-C-A | not specified | Uncertain significance (Jan 08, 2024) | ||
12-52011138-C-G | not specified | Uncertain significance (Feb 27, 2024) | ||
12-52013698-G-A | not specified | Uncertain significance (Nov 10, 2022) | ||
12-52013702-G-T | not specified | Uncertain significance (Apr 08, 2024) | ||
12-52013708-A-G | not specified | Uncertain significance (Oct 02, 2023) | ||
12-52013732-G-A | not specified | Uncertain significance (Apr 22, 2024) | ||
12-52013738-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
12-52014189-C-T | not specified | Uncertain significance (Apr 27, 2023) | ||
12-52014723-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
12-52014907-C-T | not specified | Uncertain significance (Apr 19, 2023) | ||
12-52014933-T-G | not specified | Uncertain significance (Jun 22, 2021) | ||
12-52014934-T-A | not specified | Uncertain significance (Jun 22, 2021) | ||
12-52014935-C-A | not specified | Likely benign (Jun 22, 2021) | ||
12-52014939-C-G | not specified | Uncertain significance (Jun 22, 2021) | ||
12-52014946-C-G | not specified | Uncertain significance (Jun 22, 2021) | ||
12-52014975-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
12-52014978-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
12-52014990-G-A | not specified | Uncertain significance (Sep 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TAMALIN | protein_coding | protein_coding | ENST00000293662 | 8 | 8950 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.901 | 0.0987 | 125743 | 0 | 5 | 125748 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.49 | 117 | 172 | 0.679 | 0.0000112 | 2398 |
Missense in Polyphen | 26 | 51.737 | 0.50254 | 588 | ||
Synonymous | 0.741 | 66 | 74.1 | 0.890 | 0.00000461 | 867 |
Loss of Function | 3.28 | 2 | 16.3 | 0.123 | 8.61e-7 | 191 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000904 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000879 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in intracellular trafficking and contributes to the macromolecular organization of group 1 metabotropic glutamate receptors (mGluRs) at synapses. {ECO:0000250}.;
- Pathway
- phosphoinositides and their downstream targets
(Consensus)
Recessive Scores
- pRec
- 0.152
Haploinsufficiency Scores
- pHI
- 0.647
- hipred
- Y
- hipred_score
- 0.697
- ghis
- 0.432
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Grasp
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- signal transduction;protein localization;regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane
- Cellular component
- plasma membrane;postsynaptic density;cell junction;postsynaptic membrane;perinuclear region of cytoplasm;Schaffer collateral - CA1 synapse;glutamatergic synapse
- Molecular function
- PDZ domain binding;ADP-ribosylation factor binding;identical protein binding